Jayakanth Kankanala

1.1k total citations
30 papers, 863 citations indexed

About

Jayakanth Kankanala is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Jayakanth Kankanala has authored 30 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Infectious Diseases and 10 papers in Virology. Recurrent topics in Jayakanth Kankanala's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (10 papers) and Cancer therapeutics and mechanisms (6 papers). Jayakanth Kankanala is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (10 papers) and Cancer therapeutics and mechanisms (6 papers). Jayakanth Kankanala collaborates with scholars based in United States, United Kingdom and Japan. Jayakanth Kankanala's co-authors include Zhengqiang Wang, Stefan G. Sarafianos, Daniel J. Wilson, Karen A. Kirby, Sanjeev Kumar V. Vernekar, Michael A. Parniak, Mary C. Casey, Jiashu Xie, Hideki Aihara and Andrew D. Huber and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Jayakanth Kankanala

30 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jayakanth Kankanala United States 19 365 303 302 244 191 30 863
Shin-ichiro Hattori Japan 16 204 0.6× 128 0.4× 269 0.9× 168 0.7× 114 0.6× 36 715
Bruno Simoneau Canada 18 338 0.9× 485 1.6× 348 1.2× 241 1.0× 306 1.6× 35 1.2k
Emanuela Nizi Italy 13 238 0.7× 302 1.0× 159 0.5× 82 0.3× 96 0.5× 19 609
Merrick R. Almond United States 13 301 0.8× 243 0.8× 176 0.6× 208 0.9× 222 1.2× 24 747
Christopher K. H. Tseng United States 13 547 1.5× 252 0.8× 407 1.3× 153 0.6× 230 1.2× 14 967
Xiangyi Jiang China 14 275 0.8× 322 1.1× 345 1.1× 274 1.1× 167 0.9× 43 729
Daniel Brian Nichols United States 12 214 0.6× 97 0.3× 339 1.1× 67 0.3× 130 0.7× 18 701
Francesca Curreli United States 19 431 1.2× 222 0.7× 503 1.7× 415 1.7× 231 1.2× 38 1.2k
Christina Calmels France 21 583 1.6× 201 0.7× 528 1.7× 521 2.1× 142 0.7× 37 1.1k
Yanming Du United States 21 434 1.2× 290 1.0× 305 1.0× 49 0.2× 371 1.9× 51 1.2k

Countries citing papers authored by Jayakanth Kankanala

Since Specialization
Citations

This map shows the geographic impact of Jayakanth Kankanala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayakanth Kankanala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayakanth Kankanala more than expected).

Fields of papers citing papers by Jayakanth Kankanala

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayakanth Kankanala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayakanth Kankanala. The network helps show where Jayakanth Kankanala may publish in the future.

Co-authorship network of co-authors of Jayakanth Kankanala

This figure shows the co-authorship network connecting the top 25 collaborators of Jayakanth Kankanala. A scholar is included among the top collaborators of Jayakanth Kankanala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayakanth Kankanala. Jayakanth Kankanala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Senaweera, Sameera, Jayakanth Kankanala, Yan Wang, et al.. (2021). Discovery of N-benzyl hydroxypyridone carboxamides as a novel and potent antiviral chemotype against human cytomegalovirus (HCMV). Acta Pharmaceutica Sinica B. 12(4). 1671–1684. 7 indexed citations
3.
Wang, Lei, Mary C. Casey, Sanjeev Kumar V. Vernekar, et al.. (2020). Novel HIV-1 capsid-targeting small molecules of the PF74 binding site. European Journal of Medicinal Chemistry. 204. 112626–112626. 19 indexed citations
4.
Kiselev, Evgeny, et al.. (2019). Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors. DNA repair. 85. 102747–102747. 15 indexed citations
5.
Tang, Jing, Ha T., Andrew D. Huber, et al.. (2019). Pharmacophore-based design of novel 3-hydroxypyrimidine-2,4-dione subtypes as inhibitors of HIV reverse transcriptase-associated RNase H: Tolerance of a nonflexible linker. European Journal of Medicinal Chemistry. 166. 390–399. 20 indexed citations
6.
Tang, Jing, Andrew D. Huber, Jennifer J. Wolf, et al.. (2018). 5-Aminothiophene-2,4-dicarboxamide analogues as hepatitis B virus capsid assembly effectors. European Journal of Medicinal Chemistry. 164. 179–192. 17 indexed citations
7.
Ribeiro, Carlos J. A., Jayakanth Kankanala, Ke Shi, et al.. (2018). New fluorescence-based high-throughput screening assay for small molecule inhibitors of tyrosyl-DNA phosphodiesterase 2 (TDP2). European Journal of Pharmaceutical Sciences. 118. 67–79. 15 indexed citations
8.
Wang, Lei, Jing Tang, Andrew D. Huber, et al.. (2018). 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity. European Journal of Medicinal Chemistry. 156. 652–665. 27 indexed citations
9.
Lee, John K., Thomas Lee, Jayakanth Kankanala, et al.. (2018). The substrate-binding cap of the UDP-diacylglucosamine pyrophosphatase LpxH is highly flexible, enabling facile substrate binding and product release. Journal of Biological Chemistry. 293(21). 7969–7981. 18 indexed citations
10.
Ribeiro, Carlos J. A., Jayakanth Kankanala, Jiashu Xie, et al.. (2018). Triazolopyrimidine and triazolopyridine scaffolds as TDP2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 29(2). 257–261. 23 indexed citations
11.
Wang, Lei, Jing Tang, Andrew D. Huber, et al.. (2018). 6-Biphenylmethyl-3-hydroxypyrimidine-2,4-diones potently and selectively inhibited HIV reverse transcriptase-associated RNase H. European Journal of Medicinal Chemistry. 156. 680–691. 23 indexed citations
12.
Kankanala, Jayakanth, Yan Wang, Robert J. Geraghty, & Zhengqiang Wang. (2018). Hydroxypyridonecarboxylic Acids as Inhibitors of Human Cytomegalovirus pUL89 Endonuclease. ChemMedChem. 13(16). 1658–1663. 15 indexed citations
13.
Kankanala, Jayakanth, Karen A. Kirby, Andrew D. Huber, et al.. (2017). Design, synthesis and biological evaluations of N-Hydroxy thienopyrimidine-2,4-diones as inhibitors of HIV reverse transcriptase-associated RNase H. European Journal of Medicinal Chemistry. 141. 149–161. 37 indexed citations
14.
Kankanala, Jayakanth, Christophe Marchand, Monica Abdelmalak, et al.. (2016). Isoquinoline-1,3-diones as Selective Inhibitors of Tyrosyl DNA Phosphodiesterase II (TDP2). Journal of Medicinal Chemistry. 59(6). 2734–2746. 58 indexed citations
15.
Wang, Yan, Lili Mao, Jayakanth Kankanala, Zhengqiang Wang, & Robert J. Geraghty. (2016). Inhibition of Human Cytomegalovirus pUL89 Terminase Subunit Blocks Virus Replication and Genome Cleavage. Journal of Virology. 91(3). 23 indexed citations
16.
Fearnley, Gareth W., Gina A. Smith, Jayakanth Kankanala, et al.. (2015). Receptor tyrosine kinase structure and function in health and disease. SHILAP Revista de lepidopterología. 2(4). 476–502. 17 indexed citations
17.
Kankanala, Jayakanth, Gareth W. Fearnley, Matthew Gage, et al.. (2014). In Silico Design and Biological Evaluation of a Dual Specificity Kinase Inhibitor Targeting Cell Cycle Progression and Angiogenesis. PLoS ONE. 9(11). e110997–e110997. 10 indexed citations
18.
Foster, Toshana L., Gary S. Thompson, Arnout P. Kalverda, et al.. (2013). Structure-Guided Design Affirms Inhibitors of Hepatitis C Virus p7 as a Viable Class of Antivirals Targeting Virion Release. Hepatology. 59(2). 408–422. 48 indexed citations
19.
Kankanala, Jayakanth, et al.. (2011). Indolinones and anilinophthalazines differentially target VEGF‐A‐ and basic fibroblast growth factor‐mediated responses in primary human endothelial cells. British Journal of Pharmacology. 165(1). 245–259. 14 indexed citations
20.
Kankanala, Jayakanth, et al.. (2011). A combinatorialin silicoand cellular approach to identify a new class of compounds that target VEGFR2 receptor tyrosine kinase activity and angiogenesis. British Journal of Pharmacology. 166(2). 737–748. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin-ichiro Hattori Breakdown of academic impact, for papers by Bruno Simoneau Breakdown of academic impact, for papers by Emanuela Nizi Breakdown of academic impact, for papers by Merrick R. Almond Breakdown of academic impact, for papers by Christopher K. H. Tseng Breakdown of academic impact, for papers by Xiangyi Jiang Breakdown of academic impact, for papers by Daniel Brian Nichols Breakdown of academic impact, for papers by Francesca Curreli Breakdown of academic impact, for papers by Christina Calmels Breakdown of academic impact, for papers by Yanming Du
Rankless by CCL
2026